Transcutaneous Non-Invasive Neuromodulation

Non-invasive neuromodulation refers to the use of new and emerging technologies to improve motor control acquisition in children and adults through the neuroplasticity of the nervous system. Craggs and McFarlane (1999), defined neuromodulation as "activity in one neural pathway modulating the pre-existing activity in another through synaptic interaction".  A large number of recent studies and findings provide hope for improved outcomes for children with cerebral palsy, spina bifida, and spinal cord injuries.

​

Non-invasive neuromodulation may improve ease of mobility, decrease spasticity, increase gait speed, increase balance and energy, vision processing, oral motor function, and overall proprioceptive input. If you are interested in reading more on Dr. Reggie Edgerton's, Parag Gad, and Dr. Susan Hastings' pioneering work in the field of spinal stim, click here.

 

As a strategic advisor for SpineX, a clinical-stage bioelectric MedTech company working to bring the first non-invasive spinal stimulation device (SCiPTM) to market for the pediatric population, Kristin supports therapeutic treatment design for research purposes at SpineX’s Los Angeles clinic. She has provided treatment in studies ranging from 6 to 20 weeks, studying the effectiveness of the SCiP device in the pediatric and in the adult population. If you or someone you know is interested in participating in a clinical trial, check out SpineX.co to learn more about hospital trials in your area.